Hybrid or catheter ablation for atrial fibrillation in hypertrophic heart
Part of Heart & circulation clinical trials.
This trial compares two procedures to treat atrial fibrillation (an irregular heartbeat) in people who also have hypertrophic cardiomyopathy (thickened heart muscle). It looks at whether the hybrid approach or a catheter-based approach works better for controlling symptoms and heart rhythm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have hypertrophic cardiomyopathy diagnosed by scan measurements of thick heart muscle
- Your left-heart outflow blockage is not severe (peak pressure gradient under 30 mmHg)
- You have persistent atrial fibrillation (episodes lasting more than 7 days but under 3 years) and symptoms that haven’t improved with medications
- You can understand the study and sign informed consent
- You should not have large left atrium, major pumping weakness, or recent stroke, and you must be able to take blood thinners if needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies catheter ablation, a procedure that targets heart rhythm triggers, for people with atrial fibrillation (an irregular heartbeat). It may help improve rhythm control, but you must meet specific heart and testing requirements and avoid certain conditions.
This study tests whether a catheter ablation procedure can help people with atrial fibrillation and a kind of heart failure where the heart pumps normally but doesn't relax properly (HFpEF). It looks at whether the procedure can improve symptoms and heart function.
This trial tests whether a procedure called catheter ablation (which fixes the heart's electrical signals) can help people with heart failure and atrial fibrillation. It focuses on those whose heart pumping strength is mildly reduced or preserved (above 40%).
This trial tests whether early catheter ablation (a procedure to fix irregular heartbeats) helps people who have both heart failure and atrial fibrillation. It looks at how this treatment affects your heart function and quality of life.
This trial tests whether a catheter procedure that treats atrial fibrillation works better than standard care for people with heart failure with preserved ejection fraction. It aims to improve heart rhythm symptoms and overall outcomes compared with conventional treatment.
This trial looks at whether a special heart rhythm treatment called “ablation” works well when done during certain heart operations. It may help reduce atrial fibrillation (AF) symptoms or future abnormal rhythm episodes for people who are already having surgery.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.